PHILADELPHIA (March 31, 2009) – Hahnemann University Hospital’s ventricular assist device program has earned the Gold Seal of Approval™ for health care quality. Ventricular assist devices (VAD) are mechanical pumps that allow damaged hearts to continue functioning while patients either await a heart transplant, or for destination therapy when transplant is not a viable option.
“Hahnemann sought accreditation for our VAD program because we wanted to demonstrate our commitment to our patient’s safety and quality care,” said George Amrom, M.D., chief medical officer of Hahnemann University Hospital. “Ventricular Assist Devices continue to become more sophisticated and allow our patients a treatment option that had not been available to them in the past.”
To earn this distinction, a disease management program undergoes an extensive, unannounced, on-site evaluation by a team of Joint Commission reviewers every two years. The program is evaluated against Joint Commission standards through an assessment of a program’s processes, the program’s ability to evaluate and improve care within its own organization, and interviews with patients and staff.
“This certification means Hahnemann University Hospital does the right things and does them well for ventricular assist device patients,” says Jean E. Range, M.S., R.N., C.P.H.Q., executive director, Disease-Specific Care Certification, Joint Commission.
The Joint Commission launched its Disease-Specific Care Certification program in 2002. It is the first program of its kind in the country to certify disease management programs. A list of programs certified by the Joint Commission is available at www.jointcommission.org.
About Hahnemann University Hospital
Hahnemann University Hospital is a 541-bed academic medical center at Broad and Vine Streets in Philadelphia, Pa. The hospital is a tertiary care institution that specializes in cardiac services, heart failure and transplantation, OB/GYN, orthopedics, medical, surgical and radiation oncology, bone marrow transplantation, renal dialysis and kidney/pancreas/liver transplantation. Hahnemann is recognized by the American Heart Association as a leader in coronary artery disease and heart failure treatments. The hospital performed one of the city’s first kidney transplants in 1963 and one of the first bone marrow transplants in 1976. Hahnemann became Philadelphia’s first Level I Regional Resource Trauma Center for adults in 1986, and since then has been served by MidAtlantic MedEvac, an aeromedical transport program for critically ill patients. Hahnemann is proud to be the first hospital in Philadelphia to join with The Wellness Community of Philadelphia to offer onsite support and education services to cancer patients and their families. Hahnemann is fully accredited by the Joint Commission on the Accreditation of Healthcare Organizations, the nation’s oldest and largest hospital accreditation agency. An affiliate of Drexel University College of Medicine, Hahnemann University Hospital is part of Tenet Pennsylvania, which also includes St. Christopher’s Hospital for Children. To learn more about Hahnemann, visit www.hahnemannhospital.com
Terms And Conditions
Notice of Privacy Practices
Hahnemann University Hospital | 230 N Broad St, Philadelphia, PA 19102
© 2002-2014 Hahnemann University Hospital, All Rights Reserved.